Cullinan Therapeutics, Inc. Ratios

Ratios Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin -356.25%
EBIT Margin -358.73%
EBITDA Margin -360.67%
Operating Margin -358.73%
Net Margin -356.25%
FCF Margin -229.28%
Efficiency
Assets Average 325.95M499.15M
Equity Average 312.84M480.20M
Invested Capital 200.31M425.37M535.03M
Asset Utilization Ratio 0.06
Leverage & Solvency
Equity Ratio 0.930.970.95
Dividends & Payouts
FCF Payout Ratio -0.26-0.03
Valuation
Enterprise Value -208.90M383.99M15.61M435.93M709.21M
Market Capitalization 674.05M482.90M435.93M709.21M
Return Ratios
Return on Sales -3.56%
Return on Capital Employed -0.22%0.30%
Return on Invested Capital 0.22%
Return on Assets -0.21%0.22%
Return on Equity -0.22%0.23%